Three Commissioners for the Commission on Human Medicines

Closed
Body: Commission on Human Medicines
Appointing Department: Department of Health
Sector: Health
Location: London
Number of Vacancies: 3
Remuneration: Commissioners are currently remunerated at the standard rate of £325 per day.
Time Requirements: Approximately 22 days per year, including 11 meetings.

Campaign Timeline

  • Competition Launched

    26/01/2018

  • Closed for Applications

    09/03/2018

  • Panel Sift

    28/03/2018

  • Final Interview Date

    11/05/2018

  • Announcement

    TBC

 

Assessment Panel

Vacancy Description

The Secretary of State for Health and Social Care is looking to appoint one lay and two specialist Commissioners to the Commission on Human Medicines (CHM). CHM is an Advisory Non-Departmental Public Body, set up in law to advise UK Health Ministers on the safety, quality and efficacy of medicines for human use and on the adverse drug reactions of marketed products.

As a Commissioner of the CHM you will be required to possess or develop a working knowledge and understanding of the UK/European medicines regulatory procedures. Commissioners consider, comment and contribute by drawing on their individual expertise and judgement, on all agenda items and assist the CHM to frame clear and unequivocal advice to Ministers.

We are looking for skilled communicators with the ability to operate effectively on a national expert scientific committee. The ability to assimilate complex scientific information at short notice and being prepared to contribute actively to the work of the CHM is essential.

The two specialist post applicants will need to be recognised by their peers and/or be Fellows of the relevant Royal Colleges and be either a Cardiologist or Pharmaco-toxicologist. An interest in pharmacogenomics/ pharmacogenetics would be an advantage.

Person Specification

Role and Responsibilities of the Commissioner

Commissioners are required to:

  • possess or develop a working knowledge and understanding of the UK/European medicines regulatory procedures
  • attend all scheduled and unscheduled meetings of the CHM (and to be present for the whole meeting)
  • consider, comment and contribute by drawing on their individual expertise and judgement, as appropriate, on all agenda items and to assist the CHM to frame clear and unequivocal advice to Ministers in accordance with the CHM’s terms of reference
  • be able and prepared to speak on a range of relevant issues and not just on their own areas of specialism
  • provide formal and informal advice to Ministers between meetings when required
  • provide advice relating to applications in the European Procedures and occasionally to attend the European Medicines Agency as part of the UK delegation as necessary
  • contribute to and ensure the CHM’s advice takes account of a wider view of risk and benefit, particularly as it is perceived by patients, carers and other members of the public

Qualities required for the role of a Commissioner

To be considered, you must be able to demonstrate that you have the qualities, skills and experience to meet all the essential criteria for appointment.

Essential Criteria

  • ability to operate effectively on a national expert scientific committee
  • be skilled communicators
  • ability to assimilate complex scientific information at short notice
  • ability and prepared to contribute actively to the work of the CHM

In addition, for the two specialist posts successful candidates should also be:

  • recognised by their peers and/or be Fellows of the relevant Royal Colleges
  • be either a Cardiologist or Pharmaco-toxicologist. An interest in pharmacogenomics/pharmacogenetics would be an advantage

Additional Information

Background on some aspects of the CHM’s work

The secretariat to the CHM produces an Annual Report at the end of each calendar year which is laid before Parliament and made public.

A link to the 2016 report is available through the Gov.UK website: –

https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/634153/WEB_Statutory_CHM___BPC_Annual_Report_2016.pdf

Attachments
Monitoring form
GUARANTEED INTERVIEW SCHEME
Information pack final closing 9.3.18
Return to Search